CrossRef Prediction of Cancer Incidence and Mortality in Korea, 2023 Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo Cancer Research and Treatment.2023
When inspecting fasting triglyceride levels at the first timepoint after initiating MAD therapy, low free carnitine showcased a 36.56% triglyceride level increase that was significantly different ( p = 0.0386) compared to 1.37% triglyceride level decrease in the normal free carnitine group
Higher doses can cause discomfort, like: Nausea or stomach pain A fishy odour from the body or breath Loose stools or diarrhoea in those with sensitive digestion These effects are dependent on the dosage
Atkinson-Clement C, Pinto S, Eusebio A, Coulon O
3 Clinical Evidence, Safety, and Regulatory Status of the Wolverine Stack From a preclinical standpoint, available animal toxicology studies have not shown any overt adverse effects for BPC-157